Cubist Systematic Strategies, LLC Aldeyra Therapeutics, Inc. Transaction History

Cubist Systematic Strategies, LLC

$15.8 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$1.47 - $6.06 $4,108 - $16,937	-2,795 Reduced 18.72%	12,138 $42,000
Q3 2023 Nov 14, 2023	BUY	$6.11 - $8.16 $91,240 - $121,853	14,933 New	14,933 $99,000
Q1 2023 May 15, 2023	BUY	$5.77 - $9.93 $33,217 - $57,167	5,757 New	5,757 $57,000
Q3 2022 Nov 14, 2022	BUY	$3.8 - $7.74 $91,154 - $185,667	23,988 Added 25.99%	116,285 $621,000
Q3 2022 Nov 14, 2022	BUY	$3.8 - $7.74 $91,154 - $185,667	23,988 Added 25.99%	116,285 $621,000
Q2 2022 Aug 15, 2022	BUY	$2.43 - $4.85 $190,298 - $379,813	78,312 Added 559.97%	92,297 $368,000
Q1 2022 May 16, 2022	SELL	$3.25 - $5.17 $228,660 - $363,745	-70,357 Reduced 83.42%	13,985 $62,000
Q4 2021 Feb 14, 2022	BUY	$3.5 - $9.63 $143,815 - $395,696	41,090 Added 95.0%	84,342 $337,000
Q3 2021 Nov 15, 2021	SELL	$7.94 - $11.31 $616,120 - $877,622	-77,597 Reduced 64.21%	43,252 $380,000
Q2 2021 Aug 16, 2021	BUY	$10.44 - $14.85 $393,922 - $560,320	37,732 Added 45.4%	120,849 $1.37 Million
Q1 2021 May 17, 2021	BUY	$6.53 - $14.42 $384,355 - $848,761	58,860 Added 242.65%	83,117 $987,000
Q4 2020 Feb 16, 2021	BUY	$6.31 - $8.13 $145,773 - $187,819	23,102 Added 2000.17%	24,257 $166,000
Q3 2020 Nov 16, 2020	BUY	$4.0 - $7.53 $4,620 - $8,697	1,155 New	1,155 $9,000
Q1 2020 May 15, 2020	SELL	$1.62 - $6.4 $24,543 - $96,960	-15,150 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$4.73 - $7.98 $71,659 - $120,897	15,150 New	15,150 $88,000
Q3 2019 Nov 14, 2019	SELL	$4.41 - $6.12 $22,367 - $31,040	-5,072 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$6.0 - $9.0 $30,432 - $45,648	5,072 New	5,072 $30,000

Others Institutions Holding ALDX

# of Institutions

117

Shares Held

36.2M

Call Options Held

196K

Put Options Held

142K

Perceptive Advisors LLC New York, NY

9.28M
Shares

$46.4 Million
1.31% of portfolio
Knoll Capital Management, LLC Miami, FL

5.48M
Shares

$27.4 Million
14.56% of portfolio
Vanguard Group Inc Valley Forge, PA

3.76M
Shares

$18.8 Million
0.0% of portfolio
Black Rock Inc. New York, NY

3.62M
Shares

$18.1 Million
0.0% of portfolio
Kennedy Capital Management, Inc. St Louis, MO

1.88M
Shares

$9.41 Million
0.24% of portfolio

View Full List

About Aldeyra Therapeutics, Inc.

Ticker ALDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,323,100
Market Cap $292M
Description
Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...

More about ALDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account